ClinicalTrials.Veeva

Menu

Quantifying Physical and Biochemical Factors That Contribute to Primary Graft Dysfunction After Lung Transplantation

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Primary Graft Dysfunction

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Primary graft dysfunction (PGD or lung reperfusion edema) complicates 10 to 20% of lung transplantations and leads to severe early and late postoperative complications. Its pathophysiology remains unclear but may involve graft ischemia-reperfusion, increased vascular permeability, pneumocyte dysfunction and finally alveolar flooding that impair gas exchange and blood oxygenation.Its substrate, namely extravascular lung water (EVLW), can now be clinically measured with minimally invasive Intensive Care Unit monitors (PiCCO2®, Pulsion Medical Systems) that also provides a physical estimate of pulmonary vascular permeability (PVPI). Similarly, biochemical correlates of vascular permeability (ICAM-1) and pneumocyte dysfunction (RAGE) can now be measured in plasma samples. Our study aims at quantifying physical and biochemical markers of PGD and assess their diagnosis and prognosis values.

Enrollment

45 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Lung transplant recipient
  • Age > 18 years
  • Signed informed consent
  • Social security affiliation

Exclusion criteria

  • Age<18
  • Pregnancy or lactation
  • Contraindication to femoral arterial catheterization
  • Patient refusal

Trial contacts and locations

4

Loading...

Central trial contact

Julien Pottecher, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems